XML 31 R20.htm IDEA: XBRL DOCUMENT v3.19.1
Note 7 - Stockholders' Equity (Tables)
9 Months Ended
Mar. 31, 2019
Notes Tables  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   
Weighted
Average,
March 31,
2019
   
 
Range,
March 31,
2019
   
Weighted
Average,
March 31,
2018
   
 
Range,
March 31,
2018
 
Volatility
   
69%
   
 58%
-
76%
     
74%
   
 68%
-
75%
 
Dividend yield
   
-
   
 
-
 
     
-
   
 
-
 
 
Risk-free interest rate
   
2.71%
   
 2.52%
-
2.78%
     
2.44%
   
 1.75%
-
2.64%
 
Expected term (years)
   
3.8
   
 1.9
to
4.3
     
5
   
 3
-
6
 
Share-based Payment Arrangement, Option, Activity [Table Text Block]
   
 
 
 
 
Options
   
 
Weighted-
Average
Exercise
Price
   
Weighted-
Average
Remaining
Contractual
Life
   
 
 
Aggregate
Intrinsic
Value
 
Outstanding at July 1, 2018
   
6,827,225
    $
1.11
     
3.8
    $
-
 
Granted
   
350,000
     
0.68
     
 
     
 
 
Exercised
   
-
     
-
     
 
     
 
 
Forfeited
   
-
     
-
     
 
     
 
 
Expired
   
(70,625
)    
1.26
     
 
     
 
 
Outstanding at March 31, 2019
   
7,106,600
    $
1.09
     
3.3
    $
57,050
 
Exercisable at March 31, 2019
   
7,106,600
    $
1.09
     
3.3
    $
57,050
 
Schedule of Nonvested Share Activity [Table Text Block]
   
 
 
Options
   
Weighted Average
Grant-Date Fair
Value
 
Nonvested at July 1, 2018
   
-
    $
-
 
Granted
   
350,000
     
0.35
 
Vested
   
(350,000
)    
0.35
 
Nonvested at March 31, 2019
   
-
    $
-
 
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
   
Three
months
ended
March 31,
2019
   
Three
months
ended
March 31,
2018
   
Nine months
ended
March 31,
2019
   
Nine months
ended
March 31,
2018
 
General and administrative:
                               
Fair value of stock bonuses expensed
  $
-
    $
1,500
    $
-
    $
8,723
 
Change in fair value from modification of option terms
   
-
     
-
     
211,185
     
243,761
 
Change in fair value from modification of warrant terms
   
-
     
7,091
     
118,233
     
163,956
 
Fair value of stock options expensed
   
5,250
     
682,485
     
97,375
     
782,135
 
Total
  $
5,250
    $
691,076
    $
426,793
    $
1,198,575
 
                                 
Research and development:
                               
Fair value of stock bonus expensed
  $
-
    $
-
    $
-
    $
15,098
 
Change in fair value from modification of option terms
   
-
     
-
     
11,115
     
105,895
 
Change in fair value from modification of warrant terms
   
-
     
219
     
44,793
     
132,896
 
Fair value of stock options expensed
   
-
     
587,215
     
25,875
     
587,215
 
Total
  $
-
    $
587,434
    $
81,783
    $
841,104